
Sign up to save your podcasts
Or
In this episode, Dr. Valentin Fuster reviews five pivotal studies from September 2024, focusing on antithrombotic strategies and diabetes treatments. Key insights include the efficacy of dual antithrombotic therapy over triple therapy, the benefits of anticoagulation alone post-left atrial appendage occlusion, and the superior cardiovascular outcomes of SGLT2 inhibitors and GLP-1 receptor agonists in diabetes management.
4.2
154154 ratings
In this episode, Dr. Valentin Fuster reviews five pivotal studies from September 2024, focusing on antithrombotic strategies and diabetes treatments. Key insights include the efficacy of dual antithrombotic therapy over triple therapy, the benefits of anticoagulation alone post-left atrial appendage occlusion, and the superior cardiovascular outcomes of SGLT2 inhibitors and GLP-1 receptor agonists in diabetes management.
131 Listeners
325 Listeners
864 Listeners
496 Listeners
22 Listeners
31 Listeners
3,336 Listeners
90 Listeners
138 Listeners
1,095 Listeners
61 Listeners
39 Listeners
185 Listeners
349 Listeners
427 Listeners